E.P.T. Certainty 1-STEP Pregnancy Test
by Unipath, Ltd. 510(k)
Active
510(k) K061769
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK061769 | Date3 Jul 2006 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LCX
- FDA applicant
- Unipath , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1155
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The E.P.T. Certainty 1-Step Pregnancy Test is an over-the-counter urine hCG test intended for the detection of pregnancy. It is a Class 2 Chemistry device with product code LCX, designed to detect human chorionic gonadotropin in urine samples.
The test is indicated for use from four days before the expected period. It is supplied as a single-use device and is not MRI safe. The device is authorized under FDA 510(k) clearance with K number K061769, received on June 23, 2006, and cleared on July 3, 2006.
Other devices from Unipath, Ltd.
Questions
AI-generated answers, 23 Sep 2026
What is the E.P.T. Certainty 1-Step Pregnancy Test used for?
It is intended for the detection of human chorionic gonadotropin (hCG) in urine to determine pregnancy. The test can be used from four days before the expected period, providing early results for users seeking confirmation of pregnancy.
How is the E.P.T. Certainty 1-Step Pregnancy Test supplied and is it reusable?
The device is supplied as a single-use test kit and is not designed for reuse. Each test is intended for one-time application only, ensuring reliable performance and reducing the risk of contamination or inaccurate results from repeated use.
What regulatory clearance does the E.P.T. Certainty 1-Step Pregnancy Test have?
The device is authorized under FDA 510(k) clearance with K number K061769, which was received on June 23, 2006, and cleared on July 3, 2006. It is classified as a Class 2 device with product code LCX in the Clinical Chemistry specialty.